

MCQOPTIONS
Saved Bookmarks
This section includes 11 Mcqs, each offering curated multiple-choice questions to sharpen your Virology knowledge and support exam preparation. Choose a topic below to get started.
1. |
Neuraminidase is a surface protein of the influenza A virus. |
A. | True |
B. | False |
Answer» B. False | |
2. |
Lamivudine is an analog of cytidine. |
A. | True |
B. | False |
Answer» B. False | |
3. |
Which of the following is used in the treatment of infection from RNA viruses? |
A. | Zidovudine |
B. | Ribavirin |
C. | Ritonavir |
D. | Enfuvirtide |
Answer» C. Ritonavir | |
4. |
Which of the following is used to treat the infection from cytomegalovirus? |
A. | Dideoxycytidine |
B. | Azidothymidine |
C. | Ganciclovir |
D. | Dideoxyinosine |
Answer» B. Azidothymidine | |
5. |
Which of the following antiviral drug is used to treat the infection from herpes simplex virus? |
A. | Aciclovir |
B. | Azidothymidine |
C. | Dideoxycytidine |
D. | Dideoxyinosine |
Answer» B. Azidothymidine | |
6. |
Which of the following is used to treat rubella? |
A. | ZMR |
B. | MMR |
C. | RMR |
D. | RAR |
Answer» C. RMR | |
7. |
Who developed the treatment for poliovirus? |
A. | Jonas Salk |
B. | Albert Sabin |
C. | Alexander Fleming |
D. | Edward Jenner |
Answer» B. Albert Sabin | |
8. |
Which of the following viruses are made by the mass production of virulent viruses? |
A. | Inactivated virus vaccines |
B. | Live recombinant virus vaccines |
C. | Virion subunit vaccines |
D. | Live attenuated virus vaccines |
Answer» B. Live recombinant virus vaccines | |
9. |
Which of the following vaccine contains a mutant strain of a virus that has been derived from a wild-type virulent strain? |
A. | Inactivated virus vaccines |
B. | Live recombinant virus vaccines |
C. | Virion subunit vaccines |
D. | Live attenuated virus vaccines |
Answer» E. | |
10. |
The process of producing a virus which causes a reduced amount of disease for use as a live vaccine is called ________________ |
A. | attenuation |
B. | avirulent |
C. | virulent |
D. | adjuvant |
Answer» B. avirulent | |
11. |
Which of the following is not a property of an ideal vaccine? |
A. | It should be genetically stable |
B. | It should have private support |
C. | It should be affordable |
D. | It should not have any side effects |
Answer» C. It should be affordable | |